Kayla Weiss

The Induction and Regulation of CD4 T Cells Following Respiratory Syncytial Virus Infection
Biography

The induction and regulation of CD4 T cells by cytokines following acute respiratory syncytial virus infection

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis in young children. RSV-induced disease is believed to be the result of a dysregulated host immune response resulting in immunopathology. However, there is no FDA approved vaccine for RSV and treatment only includes supportive care. Therefore, therapeutic treatments and strategies to regulate the immune response are needed to limit immunopathology for individuals with severe RSV-induced disease.

Regulation of the immune response in the mucosal lung environment is vital to maintain tissue homeostasis and prevent immunopathology. Our current data suggests that various RSV strains result in the differential induction of the innate immune and pro-inflammatory cytokine responses following infection, resulting in a differential phenotype of the CD4 T cell response. Given CD4 T cells contribute to disease severity following RSV infection, we previously investigated the role of interleukin-10 (IL-10) as a mechanism of immune regulation following RSV A2 infection. Our data demonstrated the ability of IL-10 to negatively regulate the pathogenic CD4 T cell response and suppress the severity of RSV-induced disease following RSV A2 infection. Thus determining the mechanism of differential CD4 T cell polarization and regulation by various RSV strains and its role in disease would provide critical insight into RSV pathogenesis.

Knudson CJ, Weiss KA, Stoley ME, Varga SM. Evaluation of the Adaptive Immune Response to Respiratory Syncytial Virus. Methods Mol Biol. 2016;1442:231-43. doi:10.1007/978-1-4939-3687-8_17. PubMed PMID: 27464699.

Knudson CJ, Weiss KA, Varga SM. 2015. Evaluation of the adaptive immune response to respiratory syncytial virus. R. A. Tripp and P. Jorquera (Eds.), Human respiratory syncytial virus: methods and protocols. Springer. In Press.

Weiss, K.A., Knudson, C.J., Christiaasen, A.F., and Varga, S.M. (2014). Human Respiratory Viral Infections, Animal Models of Human Respiratory Viral Infections (pp.129-162). Boca Raton, FL: CRC Press, Taylor & Francis Group.

Knudson CJ*, Weiss KA*, Hartwig SM, Varga SM. The pulmonary localization of virus-specific T lymphocytes is governed by the tissue tropism of infection. J Virol. 2014 Jun 4. pii: JVI.00329-14. [Epub ahead of print] PubMed PMID:24899187. *co-first author

Christiaansen AF, Knudson CJ, Weiss KA, Varga SM. The CD4 T cell response to respiratory syncytial virus infection. Immunol Res. 2014 May 17. [Epub ahead of print] PubMed PMID: 24838148.

Fulton RB*, Weiss KA*, Pewe LL, Harty JT, Varga SM. Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection. J Virol. 2013 Dec;87(23):12694-700. doi: 10.1128/JVI.02282-12. Epub 2013 Sep 18. PubMed PMID: 24049171; PubMed Central PMCID: PMC3838124. *co-first author

McDermott DS, Weiss KA, Knudson CJ, Varga SM. Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection. Future Virol. 2011 Aug;6(8):963-973. PubMed PMID: 21887154; PubMed Central PMCID: PMC3163480.

Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol. 2011 Sep 15;187(6):3145-54. doi: 10.4049/jimmunol.1100764. Epub 2011 Aug 15. PubMed PMID: 21844390; PubMed Central PMCID: PMC3304096.


 

Honors and Awards

  • Pre-doctoral Fellowship (5T32GM077973-0), Department of Biostatistics, University of Iowa, Iowa City, IA. 2010-2011
  • Travel Award from the Levitt Center for Virology, University of Iowa, Iowa City, IA. 2011
  • Travel Award from the Keystone Symposia, NIH/NIAID Grant, Vancouver, Canada. 2011
  • Abstract Trainee Award from the American Association of Immunologists, Boston, MA. 2012
  • Travel Award from the Levitt Center for Virology, University of Iowa, Iowa City, IA. 2012
  • Trainee Travel Award, 2012 RSV Symposium, Santa Fe, NM. 2012
  • Pre-doctoral Fellowship (5T32AI007485-17), Program in Immunology, University of Iowa, Iowa City, IA. 2011-present
Senior Scientist
Pfizer
Kayla Weiss